Abiopharma

Savara Announces the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) Has Accepted the MOLBREEVI* Marketing Authorisation Application (MAA) for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Academy Sports + Outdoors Announces Preliminary First Quarter Fiscal 2026 Sales Update Ahead of its Analyst Day

📋 Darwish Mohamad (EVP, IHS Nigeria Chief Executive Officer) plans to sell 28K shares of IHS Holding Ltd (at $8.31 each, total $233K) Filed: Apr 07, 2026 | ID: 000140

New Form SCHEDULE 13G/A - abrdn Income Credit Strategies Fund <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001445546-26-002471 <b>Size:</b> 15 KB

Valeo - Déclaration des droits de vote - Mars 2026

Valeo - Voting rights - March 2026

Johnson & Johnson - Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe

Xu Jiayuan 🟡 adjusted position in 214.2K shares (2 derivative) of FinVolution Group (FINV) Transaction Date: Apr 03, 2026 | Filing ID: 015435

Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of interest/ Changes in interest of Directors/ Chief Executive Officer

Mineros S.A. Appoints New Chief Financial Officer and Chief Technical Advisor

Sysco to Announce Third Quarter Fiscal Year 2026 Financial Results on April 28

Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital

Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy-Back Notice